Lupin informs about updates

20 Sep 2025 Evaluate

Lupin has informed that the U.S. FDA has conducted a product-specific Pre-Approval Inspection at the Company’s Pune Biotech facility from September 08 to September 19, 2025. The inspection closed with four observations. The company will address the observations and respond to the U.S. FDA within the stipulated timeframe. The company is committed to be compliant with CGMP quality standards across all its facilities.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2100.85 8.90 (0.43%)
05-Dec-2025 15:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.15
Dr. Reddys Lab 1275.50
Cipla 1521.80
Zydus Lifesciences 931.80
Lupin 2100.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×